LncRNA-HNF1A-AS1 functions as a competing endogenous RNA to activate PI3K/AKT signalling pathway by sponging miR-30b-3p in gastric cancer. 2020

Hai-Ting Liu, and Ran-Ran Ma, and Bei-Bei Lv, and Hui Zhang, and Duan-Bo Shi, and Xiang-Yu Guo, and Guo-Hao Zhang, and Peng Gao
Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Pathology, School of Basic Medical Sciences, Shandong University, Jinan, P. R. China.

Accumulating evidence demonstrated that long noncoding RNAs (lncRNAs) played important regulatory roles in many cancer types. However, the role of lncRNAs in gastric cancer (GC) progression remains unclear. RT-qPCR assay was performed to detect the expression of HNF1A-AS1 in gastric cancer tissues and the non-tumourous gastric mucosa. Overexpression and RNA interference approaches were used to investigate the effects of HNF1A-AS1 on GC cells. Insight into competitive endogenous RNA (ceRNA) mechanisms was gained via bioinformatics analysis, luciferase assays and an RNA-binding protein immunoprecipitation (RIP) assay, RNA-FISH co-localisation analysis combined with microRNA (miRNA)-pulldown assay. This study displayed that revealed expression of HNF1A-AS1 was associated with positive lymph node metastasis in GC. Moreover, HNF1A-AS1 significantly promoted gastric cancer invasion, metastasis, angiogenesis and lymphangiogenesis in vitro and in vivo. In addition, HNF1A-AS1 was demonstrated to function as a ceRNA for miR-30b-3p. HNF1A-AS1 abolished the function of the miRNA-30b-3p and resulted in the derepression of its target, PIK3CD, which is a core oncogene involved in the progression of GC. This study demonstrated that HNF1A-AS1 worked as a ceRNA and promoted PI3K/AKT signalling pathway-mediated GC metastasis by sponging miR-30b-3p, offering novel insights of the metastasis mechanism in GC.

UI MeSH Term Description Entries
D008297 Male Males
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

Hai-Ting Liu, and Ran-Ran Ma, and Bei-Bei Lv, and Hui Zhang, and Duan-Bo Shi, and Xiang-Yu Guo, and Guo-Hao Zhang, and Peng Gao
July 2019, Neoplasma,
Hai-Ting Liu, and Ran-Ran Ma, and Bei-Bei Lv, and Hui Zhang, and Duan-Bo Shi, and Xiang-Yu Guo, and Guo-Hao Zhang, and Peng Gao
January 2019, Frontiers in endocrinology,
Hai-Ting Liu, and Ran-Ran Ma, and Bei-Bei Lv, and Hui Zhang, and Duan-Bo Shi, and Xiang-Yu Guo, and Guo-Hao Zhang, and Peng Gao
November 2019, Journal of cellular and molecular medicine,
Hai-Ting Liu, and Ran-Ran Ma, and Bei-Bei Lv, and Hui Zhang, and Duan-Bo Shi, and Xiang-Yu Guo, and Guo-Hao Zhang, and Peng Gao
July 2017, Cell death & disease,
Hai-Ting Liu, and Ran-Ran Ma, and Bei-Bei Lv, and Hui Zhang, and Duan-Bo Shi, and Xiang-Yu Guo, and Guo-Hao Zhang, and Peng Gao
April 2014, Molecular cancer,
Hai-Ting Liu, and Ran-Ran Ma, and Bei-Bei Lv, and Hui Zhang, and Duan-Bo Shi, and Xiang-Yu Guo, and Guo-Hao Zhang, and Peng Gao
January 2019, Clinical science (London, England : 1979),
Hai-Ting Liu, and Ran-Ran Ma, and Bei-Bei Lv, and Hui Zhang, and Duan-Bo Shi, and Xiang-Yu Guo, and Guo-Hao Zhang, and Peng Gao
December 2016, Journal of cellular and molecular medicine,
Hai-Ting Liu, and Ran-Ran Ma, and Bei-Bei Lv, and Hui Zhang, and Duan-Bo Shi, and Xiang-Yu Guo, and Guo-Hao Zhang, and Peng Gao
January 2018, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
Hai-Ting Liu, and Ran-Ran Ma, and Bei-Bei Lv, and Hui Zhang, and Duan-Bo Shi, and Xiang-Yu Guo, and Guo-Hao Zhang, and Peng Gao
November 2019, Cell proliferation,
Hai-Ting Liu, and Ran-Ran Ma, and Bei-Bei Lv, and Hui Zhang, and Duan-Bo Shi, and Xiang-Yu Guo, and Guo-Hao Zhang, and Peng Gao
April 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Copied contents to your clipboard!